Dr. Jeffrey A. Alper, MD, PA

Dr. Alper practices at American Arthritis & Rheumatology Associates in Boca Raton, Florida.

Dr. Alper's NPI, 1689663296, was assigned on October 17, 2005. Dr. Alper graduated from University of Miami, Miller School of Medicine in 1980. Dr. Alper holds Florida license ME39139.

Dr. Alper's primary practice is American Arthritis & Rheumatology Associates, at 2255 W Glades Rd, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (561) 747-1987.

Dr. Alper's primary practice is American Arthritis & Rheumatology Associates in Boca Raton, Florida. Dr. Alper is also affiliated with Lee Memorial Hospital. The medical group on file is AARA (The American Arthritis and Rheumatology Associates). Dmand AI also links Dr. Alper to 3 more hospitals, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alper practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Alper's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Alper is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Alper's licenses on file in 3 states: Florida, Illinois and South Carolina.

Dmand AI lists arteritis, arthritis, bursitis, gout, hand joint or tendon inflammation, insomnia, joint pain and lower back pain among the conditions Dr. Alper treats.

CMS data shows 380,185 Medicare services from Dr. Alper across 16 procedure codes in 2024, for 738 Medicare patients. Medicare paid $3,259,231 for them. Every service was in an office.

CMS counts 738 Medicare patients who saw Dr. Alper in 2024. The largest group is 75 to 84, with 337 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alper's median patient age at 74, with 72% women.

In 2024, Dr. Alper wrote 2,300 Medicare Part D claims for 532 patients. 75% of them were for generic drugs. CMS names the drug for 2,074 of them, across 38 drugs with 11 or more claims each, at $3,392,488 in total drug cost. In 2023, CMS named 2,216 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Alper for performance year 2024, reported as part of a group. Dr. Alper accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Alper, published from 2019 to 2021. Dr. Alper's most frequent co-authors are Jeffrey R. Curtis, MD, Maria I. Danila and Mark Christopher Genovese, MD.

Dmand AI links Dr. Alper to 16 clinical trials, 5 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Arthritis, Psoriatic. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Alper that name 6 trials.

CMS Open Payments shows 1,255 general payments to Dr. Alper from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Flexion Therapeutics, Inc. paid the most, $5,515. It also lists 65 research payments totaling $183,680 from 2016 to 2021, naming 6 clinical trials.

Dmand AI lists 3 awards for Dr. Alper, most recently Gulfshore Life Magazine: Top Doctors in 2014.

Dr. Alper graduated from University of Miami, Miller School of Medicine in 1980. Dr. Alper is a member of ACR.

Dr. Alper is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.